The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Pharmaceuticals Market Insights and Forecast to 2028
Synopsis
Pet pharmaceutical refers specifically to medicines given to pets.
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
Market Analysis and Insights: Global Pet Pharmaceuticals Market
Due to the COVID-19 pandemic, the global Pet Pharmaceuticals market size is estimated to be worth US$ 15350 million in 2022 and is forecast to a readjusted size of US$ 23040 million by 2028 with a CAGR of 7.0% during the review period. Fully considering the economic change by this health crisis, Antiparasitic accounting for % of the Pet Pharmaceuticals global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Prevention segment is altered to an % CAGR throughout this forecast period.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
Global Pet Pharmaceuticals Scope and Segment
Pet Pharmaceuticals market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pet Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Antiparasitic
Biological Products
Antibacterial
Others
Segment by Application
Prevention
Treatment
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Pet pharmaceutical refers specifically to medicines given to pets.
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
Market Analysis and Insights: Global Pet Pharmaceuticals Market
Due to the COVID-19 pandemic, the global Pet Pharmaceuticals market size is estimated to be worth US$ 15350 million in 2022 and is forecast to a readjusted size of US$ 23040 million by 2028 with a CAGR of 7.0% during the review period. Fully considering the economic change by this health crisis, Antiparasitic accounting for % of the Pet Pharmaceuticals global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Prevention segment is altered to an % CAGR throughout this forecast period.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
Global Pet Pharmaceuticals Scope and Segment
Pet Pharmaceuticals market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pet Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Antiparasitic
Biological Products
Antibacterial
Others
Segment by Application
Prevention
Treatment
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Index1 Study Coverage
1.1 Pet Pharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Pet Pharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antiparasitic
1.2.3 Biological Products
1.2.4 Antibacterial
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pet Pharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pet Pharmaceuticals Sales Estimates and Forecasts 2017-2028
2.2 Global Pet Pharmaceuticals Revenue Estimates and Forecasts 2017-2028
2.3 Global Pet Pharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pet Pharmaceuticals Sales by Region
2.4.1 Global Pet Pharmaceuticals Sales by Region (2017-2022)
2.4.2 Global Sales Pet Pharmaceuticals by Region (2023-2028)
2.5 Global Pet Pharmaceuticals Revenue by Region
2.5.1 Global Pet Pharmaceuticals Revenue by Region (2017-2022)
2.5.2 Global Pet Pharmaceuticals Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pet Pharmaceuticals Sales by Manufacturers
3.1.1 Global Top Pet Pharmaceuticals Manufacturers by Sales (2017-2022)
3.1.2 Global Pet Pharmaceuticals Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet Pharmaceuticals in 2021
3.2 Global Pet Pharmaceuticals Revenue by Manufacturers
3.2.1 Global Pet Pharmaceuticals Revenue by Manufacturers (2017-2022)
3.2.2 Global Pet Pharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pet Pharmaceuticals Revenue in 2021
3.3 Global Pet Pharmaceuticals Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pet Pharmaceuticals Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet Pharmaceuticals Sales by Type
4.1.1 Global Pet Pharmaceuticals Historical Sales by Type (2017-2022)
4.1.2 Global Pet Pharmaceuticals Forecasted Sales by Type (2023-2028)
4.1.3 Global Pet Pharmaceuticals Sales Market Share by Type (2017-2028)
4.2 Global Pet Pharmaceuticals Revenue by Type
4.2.1 Global Pet Pharmaceuticals Historical Revenue by Type (2017-2022)
4.2.2 Global Pet Pharmaceuticals Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pet Pharmaceuticals Revenue Market Share by Type (2017-2028)
4.3 Global Pet Pharmaceuticals Price by Type
4.3.1 Global Pet Pharmaceuticals Price by Type (2017-2022)
4.3.2 Global Pet Pharmaceuticals Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pet Pharmaceuticals Sales by Application
5.1.1 Global Pet Pharmaceuticals Historical Sales by Application (2017-2022)
5.1.2 Global Pet Pharmaceuticals Forecasted Sales by Application (2023-2028)
5.1.3 Global Pet Pharmaceuticals Sales Market Share by Application (2017-2028)
5.2 Global Pet Pharmaceuticals Revenue by Application
5.2.1 Global Pet Pharmaceuticals Historical Revenue by Application (2017-2022)
5.2.2 Global Pet Pharmaceuticals Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pet Pharmaceuticals Revenue Market Share by Application (2017-2028)
5.3 Global Pet Pharmaceuticals Price by Application
5.3.1 Global Pet Pharmaceuticals Price by Application (2017-2022)
5.3.2 Global Pet Pharmaceuticals Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pet Pharmaceuticals Market Size by Type
6.1.1 North America Pet Pharmaceuticals Sales by Type (2017-2028)
6.1.2 North America Pet Pharmaceuticals Revenue by Type (2017-2028)
6.2 North America Pet Pharmaceuticals Market Size by Application
6.2.1 North America Pet Pharmaceuticals Sales by Application (2017-2028)
6.2.2 North America Pet Pharmaceuticals Revenue by Application (2017-2028)
6.3 North America Pet Pharmaceuticals Market Size by Country
6.3.1 North America Pet Pharmaceuticals Sales by Country (2017-2028)
6.3.2 North America Pet Pharmaceuticals Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pet Pharmaceuticals Market Size by Type
7.1.1 Europe Pet Pharmaceuticals Sales by Type (2017-2028)
7.1.2 Europe Pet Pharmaceuticals Revenue by Type (2017-2028)
7.2 Europe Pet Pharmaceuticals Market Size by Application
7.2.1 Europe Pet Pharmaceuticals Sales by Application (2017-2028)
7.2.2 Europe Pet Pharmaceuticals Revenue by Application (2017-2028)
7.3 Europe Pet Pharmaceuticals Market Size by Country
7.3.1 Europe Pet Pharmaceuticals Sales by Country (2017-2028)
7.3.2 Europe Pet Pharmaceuticals Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pet Pharmaceuticals Market Size by Type
8.1.1 Asia Pacific Pet Pharmaceuticals Sales by Type (2017-2028)
8.1.2 Asia Pacific Pet Pharmaceuticals Revenue by Type (2017-2028)
8.2 Asia Pacific Pet Pharmaceuticals Market Size by Application
8.2.1 Asia Pacific Pet Pharmaceuticals Sales by Application (2017-2028)
8.2.2 Asia Pacific Pet Pharmaceuticals Revenue by Application (2017-2028)
8.3 Asia Pacific Pet Pharmaceuticals Market Size by Region
8.3.1 Asia Pacific Pet Pharmaceuticals Sales by Region (2017-2028)
8.3.2 Asia Pacific Pet Pharmaceuticals Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pet Pharmaceuticals Market Size by Type
9.1.1 Latin America Pet Pharmaceuticals Sales by Type (2017-2028)
9.1.2 Latin America Pet Pharmaceuticals Revenue by Type (2017-2028)
9.2 Latin America Pet Pharmaceuticals Market Size by Application
9.2.1 Latin America Pet Pharmaceuticals Sales by Application (2017-2028)
9.2.2 Latin America Pet Pharmaceuticals Revenue by Application (2017-2028)
9.3 Latin America Pet Pharmaceuticals Market Size by Country
9.3.1 Latin America Pet Pharmaceuticals Sales by Country (2017-2028)
9.3.2 Latin America Pet Pharmaceuticals Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pet Pharmaceuticals Market Size by Type
10.1.1 Middle East and Africa Pet Pharmaceuticals Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pet Pharmaceuticals Revenue by Type (2017-2028)
10.2 Middle East and Africa Pet Pharmaceuticals Market Size by Application
10.2.1 Middle East and Africa Pet Pharmaceuticals Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pet Pharmaceuticals Revenue by Application (2017-2028)
10.3 Middle East and Africa Pet Pharmaceuticals Market Size by Country
10.3.1 Middle East and Africa Pet Pharmaceuticals Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pet Pharmaceuticals Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Zoetis Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zoetis Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Boehringer Ingelheim Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Elanco
11.4.1 Elanco Corporation Information
11.4.2 Elanco Overview
11.4.3 Elanco Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Elanco Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Elanco Recent Developments
11.5 Virbac
11.5.1 Virbac Corporation Information
11.5.2 Virbac Overview
11.5.3 Virbac Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Virbac Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Virbac Recent Developments
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Corporation Information
11.6.2 Dechra Veterinary Products Overview
11.6.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Dechra Veterinary Products Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dechra Veterinary Products Recent Developments
11.7 Ceva
11.7.1 Ceva Corporation Information
11.7.2 Ceva Overview
11.7.3 Ceva Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ceva Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Recent Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Corporation Information
11.8.2 Vetoquinol Overview
11.8.3 Vetoquinol Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Vetoquinol Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Vetoquinol Recent Developments
11.9 Ouro Fino Saude
11.9.1 Ouro Fino Saude Corporation Information
11.9.2 Ouro Fino Saude Overview
11.9.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ouro Fino Saude Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ouro Fino Saude Recent Developments
11.10 Norbrook
11.10.1 Norbrook Corporation Information
11.10.2 Norbrook Overview
11.10.3 Norbrook Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Norbrook Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Norbrook Recent Developments
11.11 Jindun
11.11.1 Jindun Corporation Information
11.11.2 Jindun Overview
11.11.3 Jindun Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jindun Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jindun Recent Developments
11.12 Chopperlvya Animal Health
11.12.1 Chopperlvya Animal Health Corporation Information
11.12.2 Chopperlvya Animal Health Overview
11.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Chopperlvya Animal Health Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Chopperlvya Animal Health Recent Developments
11.13 CAHIC
11.13.1 CAHIC Corporation Information
11.13.2 CAHIC Overview
11.13.3 CAHIC Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 CAHIC Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 CAHIC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet Pharmaceuticals Industry Chain Analysis
12.2 Pet Pharmaceuticals Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet Pharmaceuticals Production Mode & Process
12.4 Pet Pharmaceuticals Sales and Marketing
12.4.1 Pet Pharmaceuticals Sales Channels
12.4.2 Pet Pharmaceuticals Distributors
12.5 Pet Pharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pet Pharmaceuticals Industry Trends
13.2 Pet Pharmaceuticals Market Drivers
13.3 Pet Pharmaceuticals Market Challenges
13.4 Pet Pharmaceuticals Market Restraints
14 Key Findings in The Global Pet Pharmaceuticals Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Pet Pharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Antiparasitic
Table 3. Major Manufacturers of Biological Products
Table 4. Major Manufacturers of Antibacterial
Table 5. Major Manufacturers of Others
Table 6. Global Pet Pharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Pet Pharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Pet Pharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 9. Global Pet Pharmaceuticals Sales Market Share by Region (2017-2022)
Table 10. Global Pet Pharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 11. Global Pet Pharmaceuticals Sales Market Share by Region (2023-2028)
Table 12. Global Pet Pharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Pet Pharmaceuticals Revenue Market Share by Region (2017-2022)
Table 14. Global Pet Pharmaceuticals Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Pet Pharmaceuticals Revenue Market Share by Region (2023-2028)
Table 16. Global Pet Pharmaceuticals Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Pet Pharmaceuticals Sales Share by Manufacturers (2017-2022)
Table 18. Global Pet Pharmaceuticals Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Pet Pharmaceuticals Revenue Share by Manufacturers (2017-2022)
Table 20. Pet Pharmaceuticals Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Pet Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pet Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pharmaceuticals as of 2021)
Table 23. Pet Pharmaceuticals Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pet Pharmaceuticals Product Offered
Table 25. Date of Manufacturers Enter into Pet Pharmaceuticals Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pet Pharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 28. Global Pet Pharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 29. Global Pet Pharmaceuticals Sales Share by Type (2017-2022)
Table 30. Global Pet Pharmaceuticals Sales Share by Type (2023-2028)
Table 31. Global Pet Pharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Pet Pharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Pet Pharmaceuticals Revenue Share by Type (2017-2022)
Table 34. Global Pet Pharmaceuticals Revenue Share by Type (2023-2028)
Table 35. Pet Pharmaceuticals Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Pet Pharmaceuticals Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Pet Pharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 38. Global Pet Pharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 39. Global Pet Pharmaceuticals Sales Share by Application (2017-2022)
Table 40. Global Pet Pharmaceuticals Sales Share by Application (2023-2028)
Table 41. Global Pet Pharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Pet Pharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Pet Pharmaceuticals Revenue Share by Application (2017-2022)
Table 44. Global Pet Pharmaceuticals Revenue Share by Application (2023-2028)
Table 45. Pet Pharmaceuticals Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Pet Pharmaceuticals Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Pet Pharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 48. North America Pet Pharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 49. North America Pet Pharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Pet Pharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Pet Pharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 52. North America Pet Pharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 53. North America Pet Pharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Pet Pharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Pet Pharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 56. North America Pet Pharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 57. North America Pet Pharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Pet Pharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Pet Pharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 60. Europe Pet Pharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 61. Europe Pet Pharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Pet Pharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Pet Pharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 64. Europe Pet Pharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 65. Europe Pet Pharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Pet Pharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Pet Pharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 68. Europe Pet Pharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 69. Europe Pet Pharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Pet Pharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Pet Pharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Pet Pharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Pet Pharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Pet Pharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Pet Pharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Pet Pharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Pet Pharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Pet Pharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Pet Pharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Pet Pharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Pet Pharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Pet Pharmaceuticals Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Pet Pharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Pet Pharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Pet Pharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Pet Pharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Pet Pharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Pet Pharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Pet Pharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Pet Pharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Pet Pharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Pet Pharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Pet Pharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Pet Pharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Pet Pharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Pet Pharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Pet Pharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Pet Pharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Pet Pharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Pet Pharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Pet Pharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Pet Pharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Pet Pharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Pet Pharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Pet Pharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Pet Pharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
Table 107. Zoetis Corporation Information
Table 108. Zoetis Description and Major Businesses
Table 109. Zoetis Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Zoetis Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Zoetis Recent Developments
Table 112. Boehringer Ingelheim Corporation Information
Table 113. Boehringer Ingelheim Description and Major Businesses
Table 114. Boehringer Ingelheim Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Boehringer Ingelheim Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Boehringer Ingelheim Recent Developments
Table 117. Merck Corporation Information
Table 118. Merck Description and Major Businesses
Table 119. Merck Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Merck Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Merck Recent Developments
Table 122. Elanco Corporation Information
Table 123. Elanco Description and Major Businesses
Table 124. Elanco Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Elanco Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Elanco Recent Developments
Table 127. Virbac Corporation Information
Table 128. Virbac Description and Major Businesses
Table 129. Virbac Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Virbac Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Virbac Recent Developments
Table 132. Dechra Veterinary Products Corporation Information
Table 133. Dechra Veterinary Products Description and Major Businesses
Table 134. Dechra Veterinary Products Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Dechra Veterinary Products Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dechra Veterinary Products Recent Developments
Table 137. Ceva Corporation Information
Table 138. Ceva Description and Major Businesses
Table 139. Ceva Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Ceva Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Ceva Recent Developments
Table 142. Vetoquinol Corporation Information
Table 143. Vetoquinol Description and Major Businesses
Table 144. Vetoquinol Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Vetoquinol Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Vetoquinol Recent Developments
Table 147. Ouro Fino Saude Corporation Information
Table 148. Ouro Fino Saude Description and Major Businesses
Table 149. Ouro Fino Saude Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Ouro Fino Saude Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Ouro Fino Saude Recent Developments
Table 152. Norbrook Corporation Information
Table 153. Norbrook Description and Major Businesses
Table 154. Norbrook Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Norbrook Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Norbrook Recent Developments
Table 157. Jindun Corporation Information
Table 158. Jindun Description and Major Businesses
Table 159. Jindun Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Jindun Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Jindun Recent Developments
Table 162. Chopperlvya Animal Health Corporation Information
Table 163. Chopperlvya Animal Health Description and Major Businesses
Table 164. Chopperlvya Animal Health Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Chopperlvya Animal Health Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Chopperlvya Animal Health Recent Developments
Table 167. CAHIC Corporation Information
Table 168. CAHIC Description and Major Businesses
Table 169. CAHIC Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. CAHIC Pet Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. CAHIC Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Pet Pharmaceuticals Distributors List
Table 175. Pet Pharmaceuticals Customers List
Table 176. Pet Pharmaceuticals Market Trends
Table 177. Pet Pharmaceuticals Market Drivers
Table 178. Pet Pharmaceuticals Market Challenges
Table 179. Pet Pharmaceuticals Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Pharmaceuticals Product Picture
Figure 3. Global Pet Pharmaceuticals Market Share by Type in 2021 & 2028
Figure 3. Antiparasitic Product Picture
Figure 4. Biological Products Product Picture
Figure 5. Antibacterial Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pet Pharmaceuticals Market Share by Application in 2021 & 2028
Figure 8. Prevention
Figure 9. Treatment
Figure 10. Pet Pharmaceuticals Report Years Considered
Figure 11. Global Pet Pharmaceuticals Sales 2017-2028 (K Units)
Figure 12. Global Pet Pharmaceuticals Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pet Pharmaceuticals Revenue 2017-2028 (US$ Million)
Figure 14. Global Pet Pharmaceuticals Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Pet Pharmaceuticals Sales Market Share by Region (2017-2022)
Figure 16. Global Pet Pharmaceuticals Sales Market Share by Region (2023-2028)
Figure 17. North America Pet Pharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 18. North America Pet Pharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Pet Pharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Pet Pharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Pet Pharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Pet Pharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Pet Pharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Pet Pharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Pet Pharmaceuticals Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Pet Pharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Pet Pharmaceuticals Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Pet Pharmaceuticals in the World: Market Share by Pet Pharmaceuticals Revenue in 2021
Figure 29. Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Pet Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 31. Global Pet Pharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 32. Global Pet Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 33. Global Pet Pharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 34. North America Pet Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 35. North America Pet Pharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 36. North America Pet Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 37. North America Pet Pharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 38. North America Pet Pharmaceuticals Sales Share by Country (2017-2028)
Figure 39. North America Pet Pharmaceuticals Revenue Share by Country (2017-2028)
Figure 40. U.S. Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Pet Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 43. Europe Pet Pharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 44. Europe Pet Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 45. Europe Pet Pharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 46. Europe Pet Pharmaceuticals Sales Share by Country (2017-2028)
Figure 47. Europe Pet Pharmaceuticals Revenue Share by Country (2017-2028)
Figure 48. Germany Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 49. France Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Pet Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Pet Pharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Pet Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Pet Pharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Pet Pharmaceuticals Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Pet Pharmaceuticals Revenue Share by Region (2017-2028)
Figure 59. China Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 62. India Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Pet Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 69. Latin America Pet Pharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Pet Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 71. Latin America Pet Pharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Pet Pharmaceuticals Sales Share by Country (2017-2028)
Figure 73. Latin America Pet Pharmaceuticals Revenue Share by Country (2017-2028)
Figure 74. Mexico Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Pet Pharmaceuticals Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Pet Pharmaceuticals Revenue Share by Country (2017-2028)
Figure 83. Turkey Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Pet Pharmaceuticals Revenue (2017-2028) & (US$ Million)
Figure 86. Pet Pharmaceuticals Value Chain
Figure 87. Pet Pharmaceuticals Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
